These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17186837)
21. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V; Hutchins B Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
22. COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma. Harrington LS; Lucas R; McMaster SK; Moreno L; Scadding G; Warner TD; Mitchell JA FASEB J; 2008 Nov; 22(11):4005-10. PubMed ID: 18753249 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats. Déciga-Campos M; López UG; Reval MI; López-Muñoz FJ Eur J Pharmacol; 2003 Jan; 460(2-3):99-107. PubMed ID: 12559369 [TBL] [Abstract][Full Text] [Related]
32. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). Wynn RL Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547 [No Abstract] [Full Text] [Related]
33. Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid mild analgesics. Higgs GA Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):233S-235S. PubMed ID: 7002184 [TBL] [Abstract][Full Text] [Related]
34. COX-2 inhibitors--a lesson in unexpected problems. Drazen JM N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947 [No Abstract] [Full Text] [Related]
35. Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Serhan CN; Levy B Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8609-11. PubMed ID: 12861081 [No Abstract] [Full Text] [Related]
36. Prostanoids and inflammatory pain. Chen L; Yang G; Grosser T Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510 [TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Mazario J; Gaitan G; Herrero JF Neuropharmacology; 2001 Jun; 40(7):937-46. PubMed ID: 11378164 [TBL] [Abstract][Full Text] [Related]
38. [Cardiovascular events: a class effect by COX-2 inhibitors]. Araujo LF; Soeiro Ade M; Fernandes Jde L; Serrano Júnior CV Arq Bras Cardiol; 2005 Sep; 85(3):222-9. PubMed ID: 16200274 [No Abstract] [Full Text] [Related]
39. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Weir MR; Sperling RS; Reicin A; Gertz BJ Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311 [TBL] [Abstract][Full Text] [Related]
40. The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. Darling RL; Romero JJ; Dial EJ; Akunda JK; Langenbach R; Lichtenberger LM Gastroenterology; 2004 Jul; 127(1):94-104. PubMed ID: 15236176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]